Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000512079 http://scihub22266oqcxt.onion/10.1159/000512079 33059353!7649687!33059353     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+Arch+Allergy+Immunol 2021 ; 182 (1): 49-52 Nephropedia Template TP {{tp|p=33059353|t=2021. Change in Allergy Practice during the COVID-19 Pandemic |pdf=|usr=}}{{33059353}} gab.com Text Change in Allergy Practice during the COVID-19 Pandemic JO: Int Arch Allergy Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33059353 #FOAvip BACKGROUND: International guidelines in asthma and allergy has been updated for COVID-19 pandemic and pandemic has caused dramatic changes in allergy and immunology services. However, it is not known whether specialty-specific recommendations for COVID-19 are followed by allergists. OBJECTIVES: By conducting this study, we aimed to determine the attitudes and experiences of adult/pediatric allergists on allergy management during COVID-19. METHOD: We used a 20-question survey to elicit data from allergists (residents and pediatric and adult allergists registered to the Turkish National Society of Allergy and Clinical Immunology) across Turkey via e-mail. We analyzed the data statistically for frequency distributions and descriptive analysis. RESULTS: A total of 183 allergists participated in the survey. Telemedicine was used for management of asthma (73%), allergic rhinitis (53%), atopic dermatitis (51%), chronic urticaria/angioedema (59%), drug hypersensitivity (45%), food allergy (48%), venom allergy (30%), anaphylaxis (22%), and hereditary angioedema (28%). Thirty-one percent of the respondents discontinued subcutaneous immunotherapy (SCIT) during the COVID-19 pandemic. Thirty-four percent of the physicians reported interruption of systemic steroid use in asthma patients, and 25% of the respondents discontinued biological therapy. CONCLUSIONS: Allergists in Turkey have been using telemedicine at a high rate during the COVID-19 pandemic for asthma and rhinitis. The continuation rate of SCIT was low while the discontinuation rate of biologicals and systemic steroid use in asthma was high in Turkey.Our study results and learning from the experiences of other countries and specialties may help to optimize allergy practice and compatibility with international guidelines. Twit Text FOAVip Change in Allergy Practice during the COVID-19 Pandemic ????Int Arch Allergy Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33059353 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33059353 #FOAvip English Wikipedia <ref>{{Cite pmid|33059353}}</ref> Change in Allergy Practice during the COVID-19 Pandemic #MMPMID33059353 Ozturk AB; Baccioglu A; Soyer O; Civelek E; Sekerel BE; Bavbek S Int Arch Allergy Immunol 2021[]; 182 (1): 49-52 PMID33059353show ga BACKGROUND: International guidelines in asthma and allergy has been updated for COVID-19 pandemic and pandemic has caused dramatic changes in allergy and immunology services. However, it is not known whether specialty-specific recommendations for COVID-19 are followed by allergists. OBJECTIVES: By conducting this study, we aimed to determine the attitudes and experiences of adult/pediatric allergists on allergy management during COVID-19. METHOD: We used a 20-question survey to elicit data from allergists (residents and pediatric and adult allergists registered to the Turkish National Society of Allergy and Clinical Immunology) across Turkey via e-mail. We analyzed the data statistically for frequency distributions and descriptive analysis. RESULTS: A total of 183 allergists participated in the survey. Telemedicine was used for management of asthma (73%), allergic rhinitis (53%), atopic dermatitis (51%), chronic urticaria/angioedema (59%), drug hypersensitivity (45%), food allergy (48%), venom allergy (30%), anaphylaxis (22%), and hereditary angioedema (28%). Thirty-one percent of the respondents discontinued subcutaneous immunotherapy (SCIT) during the COVID-19 pandemic. Thirty-four percent of the physicians reported interruption of systemic steroid use in asthma patients, and 25% of the respondents discontinued biological therapy. CONCLUSIONS: Allergists in Turkey have been using telemedicine at a high rate during the COVID-19 pandemic for asthma and rhinitis. The continuation rate of SCIT was low while the discontinuation rate of biologicals and systemic steroid use in asthma was high in Turkey.Our study results and learning from the experiences of other countries and specialties may help to optimize allergy practice and compatibility with international guidelines. |*COVID-19/epidemiology[MESH] |*SARS-CoV-2[MESH] |Adrenal Cortex Hormones/therapeutic use[MESH] |Adult[MESH] |Allergists[MESH] |Allergy and Immunology[MESH] |Attitude of Health Personnel[MESH] |Biological Products/therapeutic use[MESH] |Desensitization, Immunologic[MESH] |Humans[MESH] |Hypersensitivity/*therapy[MESH] |Pandemics[MESH] |Primary Immunodeficiency Diseases/drug therapy[MESH] |Specialization[MESH] |Surveys and Questionnaires[MESH] |Telemedicine[MESH]Change in Allergy Practice during the COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing